The Role of CD80, CD86, and CTLA4 in Alloimmune Responses and the Induction of Long-Term Allograft Survival
1999 · The Journal of Immunology · 204 citations
https://doi.org/10.4049/jimmunol.162.4.1947
T
Thomas Judge
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
104
Papers
2.1K
Citations
20
h-index
27
i10-index
Thomas Judge is an academic researcher. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Hepatitis C virus research. The author has an h-index of 20, co-authored 89 publications.
Papers by this author
worksPsoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
1995 · The Journal of Immunology · 160 citations
https://doi.org/10.4049/jimmunol.154.6.2668
Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand
1996 · The Journal of Immunology · 114 citations
https://doi.org/10.4049/jimmunol.157.1.117
Risk of Hepatobiliary-Gastrointestinal Malignancies and Appropriate Cancer Surveillance in Patients With Primary Sclerosing Cholangitis
2021 · Cureus · 5 citations
https://doi.org/10.7759/cureus.19922
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat